Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 81Colonic Neoplasms 18Neoplasm Metastasis 17Rectal Neoplasms 14Neoplasms 13Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Lung Neoplasms 4Gastrointestinal Neoplasms 4Carcinoma, Renal Cell 3Carcinoma, Neuroendocrine 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Melanoma 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Brain Neoplasms 2Adenocarcinoma 2Urinary Bladder Neoplasms 1Unresectable Metastatic Colorectal Cancer 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma 1Ras-mutated Metastatic Colorectal Cancer 1Prostatic Neoplasms 1

Interventions

Bevacizumab 19Capecitabine 15Oxaliplatin 11Irinotecan 11Cetuximab 11Fluorouracil 10Leucovorin 8aflibercept 7Panitumumab 6trifluridine tipiracil drug combination 4Nivolumab 4sintilimab 3regorafenib 3Ipilimumab 3Vemurafenib 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2HMPL-013 2Folfox protocol 2Drug Therapy 2tremelimumab 1spartalizumab 1raltitrexed 1pembrolizumab 1monoclonal antibody YYB-101 1masitinib 1irinotecan sucrosofate 1glucopyranosyl lipid-A 1folfirinox 1durvalumab 1camrelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Cancer Metastatic × IFL protocol × Clear all
NCT01571284 2018-04-17

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Sanofi

Phase 3 Completed
781 enrolled 28 charts
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡